Skip to main content
Clinical Trials/NCT03325426
NCT03325426CompletedNot Applicable

ACtivity Trackers to ImproVe Blood Pressure: a Pilot Study

University of California, San Francisco1 site in 1 country63 target enrollmentStarted: June 1, 2017Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
63
Locations
1
Primary Endpoint
Change in Mean Office Systolic BP

Study Overview

Brief Summary

The study aims to determine if use of physical activity trackers coupled with provider feedback will increase awareness of young adults of their physical fitness and improve blood pressure levels. The goal of this pilot study is feasibility, with a secondary goal of examining potential effect sizes for planning purposes for a larger randomized controlled trial.

Detailed Description

Increasing physical activity levels may improve cardiovascular health and BP levels in young individuals, especially if such strategies promote healthy lifestyles. Physical activity is currently recommended for adults CV health, but physical activity levels are known to be low in populations with diabetes or chronic kidney disease. One prior study of the use of pedometers (not associated with wireless technology or provider feedback) in children with CKD did not significantly improve physical activity levels. Supervised walking appeared to provide some benefit in individuals with type II diabetes, but overall compliance was poor. Interview of adolescents and young adults with chronic illnesses has shown preference for the use of electronic devices and online tools for disease management.Thus, use of sophisticated electronic devices such as FitBits© (wireless pedometers worn on the wrist that sync with cell phones) may improve disease control by engaging young patients in self-monitoring of their own health and lifestyle behaviors. This pilot study aims to determine if use of FitBits© coupled with provider feedback will increase awareness of young adults of their physical fitness and improve blood pressure levels.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
8 Years to 30 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •ages 8-30 receiving anti-hypertensive therapy at the time of recruitment.
  • •diabetes, non-dialysis requiring chronic kidney disease, kidney transplant, or other etiologies of hypertension
  • •have phones compatible for wireless device (FitBits©) data transmission

Exclusion Criteria

  • •history of decompensated congestive heart failure
  • •cognitive impairment
  • •unable to perform physical activity
  • •BP >180/110 mm Hg
  • •prisoners
  • •contraindication to use or wear of home activity tracker (such as allergy to activity tracker band)
  • •presence of any co-morbidity that would preclude physical activity
  • •actively using physical activity tracking devices prior to the study will be excluded.

Arms & Interventions

Usual care

No Intervention

No physical activity tracker or feedback x 6 months, then crossover to physical activity tracker x 6 months

Physical activity tracker

Experimental

Physical activity tracker x 12 months (6 months with study feedback and 6 months without)

Intervention: FitBit (Device)

Outcomes

Primary Outcomes

Change in Mean Office Systolic BP

Time Frame: Between baseline and month 6

Change in mean systolic BP using blood pressure data points collected between baseline and month 6 to provide an average change over time

Change in Mean Office Systolic BP

Time Frame: Between baseline and month 12

Change in mean systolic BP is modeled using all blood pressure data points collected between baseline and month 12 to provide an average change over time, accounting for repeated values from patients using a mixed linear regression approach.

Secondary Outcomes

  • Change in Weight (Z-score)(Months 0-12)
  • Number of Participants Retained(Months 0-12)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials